Administrators, Editors, Bots, Bureaucrats, Charaksamhita, Moderators (CommentStreams), Interface administrators, Administrators
10,235
edits
Changes
Jump to navigation
Jump to search
Line 2:
Line 2: − + Line 296:
Line 296: − + − + + − +
no edit summary
|title=Virechana
|title=Virechana
|titlemode=append
|titlemode=append
|keywords=Virechana,Virechana in ayurveda,Virechana meaning,Virechana Definition,Charak samhita,carakasamhitaonline, Indian System of Medicine
|keywords=Virechana, Virechana in ayurveda, Virechana meaning, purging therapy, Charak samhita, carakasamhitaonline, Indian System of Medicine, therapeutic purgation, purgation therapy in ayurveda, detoxification therapy, bio purification, panchakarma, treatment of excess heat, skin diseases, constipation, bowel cleansing therapy
|description=Therapeutic purgation is one of the five Panchakarma procedures mainly indicated in disorders due to excess vitiation of Pitta dosha and rakta
|description=Therapeutic purgation is one of the five Panchakarma procedures mainly indicated in disorders due to excess vitiation of Pitta dosha and rakta
|image=http://www.carakasamhitaonline.com/resources/assets/ogimgs.jpg
|image=http://www.carakasamhitaonline.com/resources/assets/ogimgs.jpg
In a case report on rheumatoid arthritis, virechana showed significant reduction in RA factor to 50 IU/ml from earlier level of 94 IU/ml. Virechana followed by avoidance of allergens reduced the CRP level from 22.7mg/l to 1.8 mh/l. After 3 months of follow up the IgE levels reduced from 680kU/l to 53.7 kU/l. The 40% relief in pain and stiffness of joints were reported soon after the virechana.<ref name=GuptaSK/>
In a case report on rheumatoid arthritis, virechana showed significant reduction in RA factor to 50 IU/ml from earlier level of 94 IU/ml. Virechana followed by avoidance of allergens reduced the CRP level from 22.7mg/l to 1.8 mh/l. After 3 months of follow up the IgE levels reduced from 680kU/l to 53.7 kU/l. The 40% relief in pain and stiffness of joints were reported soon after the virechana.<ref name=GuptaSK/>
A study conducted on 20 non-insulin dependent diabetes patients showed a better reduction in fasting blood sugar (FBS) and post prandial blood sugar (PPBS) levels through virechana, when compared with therapeutic emesis (vamana). The 51.5% reduction is observed in FBS levels after virechana, at the same time PPBS values shows 81.6% reduction. It is assumed that virechana acts on liver and pancreas as they are the sites of [[pitta dosha]]. It may reduce the hepatic glucose production or may increase the insulin secretion.<ref>Jindal N, Joshi NP. Comparative study of Vamana and Virechanakarma in controlling blood sugar levels in diabetes mellitus. Ayu. 2013 Jul;34(3):263-9. doi: 10.4103/0974-8520.123115. PMID: 24501520; PMCID: PMC3902591.</ref>
A study conducted on 20 non-insulin dependent diabetes patients showed a better reduction in fasting blood sugar (FBS) and post prandial blood sugar (PPBS) levels through virechana, when compared with therapeutic emesis (vamana). The 51.5% reduction is observed in FBS levels after virechana, at the same time PPBS values shows 81.6% reduction. It is assumed that virechana acts on liver and pancreas as they are the sites of [[pitta dosha]]. It may reduce the hepatic glucose production or may increase the insulin secretion.<ref>Jindal N, Joshi NP. Comparative study of Vamana and Virechana karma in controlling blood sugar levels in diabetes mellitus. Ayu. 2013 Jul;34(3):263-9. doi: 10.4103/0974-8520.123115. PMID: 24501520; PMCID: PMC3902591.</ref>
In another study conducted on 30 dyslipidemic persons, a significant reduction is reported in serum cholesterol, triglyceride and VLDL levels after virechana. LDL also shows reduction. Serum HDL increased significantly. Evacuation of [[pitta]] is the prime phenomenon achieved through virechana. Large amount of bile is excreted through virechana which results in reduction of cholesterol levels.<ref>Pooja BA, Bhatted SK. A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga). AYU 2016;37:32-7.</ref>
In a study on 110 overweight and obese patients, average 4.61 KG weight loss was observed after purgation therapy (virechana). <ref>Deole Y.S. Clinical study on effect of Virechana Karma [Purgation therapy] in management of Overweight and Obesity.Rasamruta,7:4 March, 2015. Available from http://www.rasamruta.com/pdf/1431946056_Revised%20%20Overweight%20and%20Obesity...pdf</ref>
In another study conducted on 30 dyslipidemia persons, a significant reduction is reported in serum cholesterol, triglyceride and VLDL levels after virechana. LDL also shows reduction. Serum HDL increased significantly. Evacuation of [[pitta]] is the prime phenomenon achieved through virechana. Large amount of bile is excreted through virechana which results in reduction of cholesterol levels.<ref>Pooja BA, Bhatted SK. A standard controlled clinical study on Virechana Karma and Lekhana Basti in the management of dyslipidemia (Medoroga). AYU 2016;37:32-7.</ref>
In a study conducted on 30 patients,virechana is reported to be more effective in reducing the signs and symptoms of psoriasis than therapeutic emesis ([[vamana]]). <ref>A. N. Parida, N.N Bhatt et al. A comparative study of vamana and virechana karma in ekakushta w.s.r to psoriasis. Ayu. 2009 Jul-Sep; VOL. 30, NO. 3: 255 - 259</ref>
In a study conducted on 30 patients, virechana is reported to be more effective in reducing the signs and symptoms of psoriasis than therapeutic emesis ([[vamana]]). <ref>A. N. Parida, N.N Bhatt et al. A comparative study of vamana and virechana karma in ekakushta w.s.r to psoriasis. Ayu. 2009 Jul-Sep; VOL. 30, NO. 3: 255 - 259</ref>
==List of theses done==
==List of theses done==